INNSBRUCK, Austria, June 18, 2013 /CNW/ - On 1 June 2013, Dr Wulf Fischer-Knuppertz, took over as Chief Executive Officer (CEO) of the internationally
operating biotech company BIOCRATES Life Sciences AG. He will from now
on be responsible for the company's corporate and strategic management.
For more than 25 years, Dr Fischer-Knuppertz has held various leading
positions in the diagnostics and pharmaceutical industries. Most
recently, 56-year-old Fischer-Knuppertz, who holds a PhD in veterinary
medicine, was General Manager with Fisher Scientific and before that
had held leading positions at Roche Diagnostics. In the field of
diagnostics, Fischer-Knuppertz brings not only ample experience in
General Management, Business Development, and Marketing and Sales but
also an in-depth know-how in personalized medicine to the job.
Fischer-Knuppertz enthusiastically commented his appointment: "I am very
attracted to BIOCRATES` unique targeted metabolomics platform
capabilities. The technology is highly innovative and has a huge
commercial potential. I look forward to establishing relationships and
innovative collaborations that will showcase this exceptional
metabolomics platform and contribute to BIOCRATES` growth and continued
The technical and scientific responsibilities within the BIOCRATES Life
Sciences AG management team will continue to be fulfilled by Chief
Technology Officer Dr Ralph Zahn. The former Chairman of the Board,
Elgar Schnegg, will be leaving the company in an atmosphere of
excellent mutual understanding on 30 June 2013.
BIOCRATES Life Sciences AG is a leading biotechnology company based in
Innsbruck/Austria focused on the development of metabolomics products
and in vitro diagnostics (IVDs) for early disease and progression
detection in areas such as nephrology, diabetes, oncology, and
endocrinology. The company's mass-spectrometry-based, standardized
metabolomic kits and IVDs provide unprecedented accuracy, precision,
and multiplexing potential that will help revolutionize the way
personalized medicine is applied in R&D and diagnostics.
For more information, please go to http://www.biocrates.com.
SOURCE: Biocrates Life Sciences AG
For further information:
BIOCRATES Life Sciences AG